Hall Christopher S., Klausner Jeffrey D., Bolan Gail A.
University of California San Francisco, Sexually Transmitted Disease Control Branch, California Department of Health Services, 1947 Center Street, Suite 201, Berkeley, CA 94704, USA.
Curr Infect Dis Rep. 2004 Feb;6(1):72-81. doi: 10.1007/s11908-004-0027-0.
Syphilis has re-emerged in the United States and elsewhere, and clinicians caring for HIV-infected patients are challenged with syphilis diagnosis and management decisions. HIV alters the natural history of syphilis to an extent that is poorly understood, and initial presentation may be more varied in coinfected patients. Although commonly available diagnostic assays for syphilis should be interpreted as usual, such tests rely on antibody measurement and may be an imperfect indicator of active infection. Assessment of all available clinical and risk behavior data remains critically important in the diagnosis of syphilis in coinfected patients. Treatment of syphilis in such patients requires stage-appropriate therapy, with careful serologic monitoring to assess response. Clinicians must have heightened appreciation of the role of frequent risk assessment, serologic screening, symptom recognition, and follow-up of treated patients, as well as an understanding of public health functions such as sex partner treatment and communicable disease reporting.
梅毒在美国及其他地区再度出现,为感染HIV的患者提供护理的临床医生在梅毒诊断和管理决策方面面临挑战。HIV对梅毒自然病程的改变程度尚不清楚,合并感染患者的初始表现可能更多样化。尽管梅毒常用诊断检测应照常解读,但此类检测依赖抗体测量,可能并非活动性感染的完美指标。评估所有可用的临床和风险行为数据对于合并感染患者的梅毒诊断仍然至关重要。此类患者的梅毒治疗需要根据分期进行适当治疗,并进行仔细的血清学监测以评估反应。临床医生必须更加重视频繁的风险评估、血清学筛查、症状识别以及对接受治疗患者的随访,同时要理解性伴侣治疗和传染病报告等公共卫生职能。